Valuation: Amedica Corporation

Market Cap 8.31M 7.57M 6.98M 6.35M 11.91M 770M 12.51M 84.92M 33.75M 421M 31.19M 30.54M 1.32B P/E 2026 *
-0.61x
P/E 2027 * -1.03x
Enterprise Value 8.31M 7.57M 6.98M 6.35M 11.91M 770M 12.51M 84.92M 33.75M 421M 31.19M 30.54M 1.32B EV / Sales 2026 *
2.47x
EV / Sales 2027 * 1.16x
Free-Float
72.59%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 2007-11-30
President - 2026-03-15
Director of Finance/CFO 41 2025-09-03
Director TitleAgeSince
Director/Board Member 63 2007-11-30
Director/Board Member 63 2025-04-02
Director/Board Member 72 2012-11-04
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 8.31M
-0.84%-5.09%-19.60%+1.07% 178B
-0.67%-2.84%-1.25%+27.12% 122B
-0.98%+0.12%-15.82%+5.56% 118B
-1.24%-4.25%-42.94%-1.34% 88.1B
-0.63%-5.55%-7.27%+70.54% 64.71B
+0.05%-2.41%+10.41%-9.90% 57.96B
-1.95%-3.98%-6.85%+41.55% 53.28B
-2.91%-4.35%-0.97%+38.45% 47.8B
-1.64%+1.50%+1.30%-2.04% 35.65B
Average -1.87%-2.63%-9.22%+19.00% 85B
Weighted average by Cap. -1.04%-2.97%-12.44%+15.68%

Financials

2026 *2027 *
Net sales 3.36M 3.06M 2.82M 2.57M 4.81M 311M 5.06M 34.34M 13.65M 170M 12.61M 12.35M 534M 7.15M 6.51M 6M 5.46M 10.24M 662M 10.76M 73.04M 29.03M 362M 26.83M 26.26M 1.14B
Net income -11.65M -10.61M -9.77M -8.89M -16.68M -1.08B -17.53M -119M -47.28M -589M -43.7M -42.78M -1.85B -11.13M -10.14M -9.34M -8.5M -15.95M -1.03B -16.76M -114M -45.2M -563M -41.77M -40.89M -1.77B
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Amedica Corporation